x The BrainGate™ technology is an advancement that allows severely disabled individuals—including those with traumatic spinal cord injury and loss of limbs—to communicate and control common every daily functions literally through thought.  BrainGate™ and BrainGate™ related technologies are currently undergoing clinical trials at various academic and research institutes, as well as hospitals throughout the United States and Europe.

Below is a list of clinical trials associated with BrainGate, as well as those being developed throughout the larger community of Brain-Computer Interfaces:

 

xxx

 

 

BrainGate2: Brown University, Mass General Hospital, and the Veterans association (Massachusetts)

 
x  

Neural Signals: Dr. Philip R. Kennedy (Georgia)

 
hippocampus mapping

 

 

Neural-Prosthesis: Dr. Theodore Berger, University of Southern California (California)

 
x

 

 

University of Tubingen: Dr. Niels Birbaumer (Germany)

 
x  

Caltech Pine Lab: Dr. Jerry Pine (California)

 
DSO logo

 

 

US Defense Science Office: Dr. Geoffrey Ling (United States)

 
  

Wadsworth Center, New York State Department of Health (New York)

 
x  

Johns Hopkins University Neuroengineering Lab (Maryland)

 
Nicolelis  

Nicolelis Lab, Duke University (North Carolina)

 
In The News
s
 
BrainGate Videos
s
 
BrainGate Science
s
 
BrainGate Technology
s.
   
Our company's core BrainGate™ technology is available through engineering and manufacturing partners:
Bionic®, Neural array microchips used in our core technology.
NeuroPort® system for human clinical trials.
Cerebus® system used for research and testing.
Contact us for more information and pricing
© 2009 BrainGate ™, Company  
press room trademarks
contact us terms of use
site map privacy